- £337.75m
- £507.46m
- £1.29bn
- 83
- 76
- 46
- 82
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 686 | 712 | 856 | 1,204 | 1,289 |
Cost of Revenue | |||||
Gross Profit | 113 | 102 | 131 | 184 | 216 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 661 | 705 | 835 | 1,169 | 1,248 |
Operating Profit | 24.9 | 7.09 | 21 | 35.1 | 41.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 23.8 | -0.995 | 18.9 | 24.9 | 36.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 18.2 | -3.39 | 13.5 | 16.9 | 28.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 17.2 | -3.75 | 12.4 | 15.3 | 26.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 17.2 | -3.75 | 12.4 | 15.3 | 26.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.217 | -0.039 | 0.141 | 0.171 | 0.283 |
Dividends per Share | |||||
Special Dividends per Share |